Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Other 1CNS 1Breast 1

Conditions

Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Leiomyoma 1Hypotension 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Phenylephrine × Clear all
NCT03592121 2020-03-12

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Applied Biology, Inc.

Phase EARLY_PHASE1 Completed
3 enrolled 6 charts
BreastOther

Breast Neoplasms, Sexual Dysfunction, Physiological, Sexual Dysfunctions, Psychological

NCT02713087 2018-10-26

Vasopressor Effects in Anesthetized Patients

University of Aarhus

Phase 4 Completed
48 enrolled
CNS

Brain Neoplasms

NCT02123069 2018-03-02

Vascular Function and Uterine Fibroids

Mayo Clinic

Completed
28 enrolled

Leiomyoma

NCT03215797 2018-01-23

Phenylephrine or Norepinephrine for a Better Hemodynamic Stability

The Second Affiliated Hospital of Dalian Medical University

Phase 3 Completed
40 enrolled

Hypotension

Data powered by HemOnc (CC BY 4.0) Colophon âš¡